Slashdot Mirror
Trans-Pacific Partnership May Endanger World Health, Newly Leaked Chapter Shows
blottsie writes WikiLeaks has released an updated version of the Trans-Pacific Partnership (TPP) chapter on intellectual property. The new version of the texts, dated May 2014, show that little improvement has been made to sections critics say would hurt free speech online. Further, some of the TPP's stipulations could have dire consequences for healthcare in developing nations. The Daily Dot reports: "Nearly all of the changes proposed by the U.S. advantage corporate entities by expanding monopolies on knowledge goods, such as drug patents, and impose restrictive copyright policies worldwide. If it came into force, TPP would even allow pharmaceutical companies to sue the U.S. whenever changes to regulatory standards or judicial decisions affected their profits. Professor Brook K. Baker of Northeastern U. School of Law [said] that the latest version of the TPP will do nothing less than lengthen, broaden, and strengthen patent monopolies on vital medications."
The fact that all of these meetings are being held in secrecy and away from public discourse is very telling. Like NAFTA, this is being touted as something great for free trade, but in fact is intended to benefit an oligarchical subset of society. Worse, that same subset has no consideration for the remainder of the citizens of the USA.
Simple, write your Reps and get them to denounce this garbage legislation. Vote them out of office if they don't denounce this bill and distance themselves. If you have 2 candidates that both want the bill, petition your own candidate on the ballot and lose the cronies.
Be warned too, that just like SOPA this is going to continually be pushed behind the scenes under new names and false pretenses.
-The wise argue that there are few absolutes, the fool argues that there are no probabilities.
Patents in pharmacuticals work well...Their application to software has been a disaster.
Something the average software engineer might not appreciate is that patents for pharmaceuticals are a bit like copyright. They cover a specific molecule, which is basically an implementation. Anybody can tweak the molecule and if it works they can sell a competing product. Of course, doing so still costs hundreds of millions of dollars in testing/development costs, so that is why we tend to only have so many molecules in each class.
The patent office sometimes does issue very broad patents in pharmaceuticals, such as patents on a gene or molecular target, but for the most part they tend to get struck down by the courts, for all the same reasons that software patents cause so much trouble.
When applied to a single molecule patents work well in pharmaceuticals because they allow a company to be rewarded for its huge initial outlay in development costs despite their very low marginal cost of production. Now, companies do try to abuse patent law to extend their monopolies and this is something that I fully support punishing harshly. Society makes a deal - we'll pay $7/pill for about 10 years so that we have new pills, but after that anybody can get them for pennies - companies do not have some kind of right to profits - it is the offer society makes because it serves all of our collective interests.
I'm also for having the NIH actually fund more end-to-end drug development where the government bears all the risk of failure, but also owns the patents (which can then be freely licensed to US-based manufacturers, or those in countries who make similar investments and reciprocate). That would in theory lead to drugs that cost pennies from day one, while leaving the private pharma industry intact until such a time as the government-funded model is proven and ramps up and generally takes over (likely slowly hiring all the private pharma employees who actually do R&D/etc).